Can a herbal supplement improve cognitive decline?

Do you feel your memory is declining? Between 25-50 per cent of the world's ageing population experience subjective cognitive complaints (SCCs) such as frequent forgetfulness, difficulties concentrating, making decisions and thinking clearly. SCCs are also linked to an increased risk of mild cognitive impairment (MCI) and Alzheimer's disease.

NICM researchers are seeking participants for a six-month clinical trial investigating a herbal and nutritional supplement for the treatment of SCCs.

Who can join?

  • Men and women over 60 years of age.
  • People who:
    • Experience problems with memory and/or thinking.
    • Are not diagnosed with dementia or mild cognitive impairment.
    • Are non-smokers.
    • Are not suffering from any serious health conditions (psychological and physical)..

What's involved?

  • A short screening questionnaire and interview over the phone.
  • A face-to-face screening session.
  • Two blood tests at your local pathology.
  • Three cognitive testing sessions and two EEG sessions (on the same day as two of the cognitive testing sessions).
  • One tablet taken twice daily (morning and night) during the six-month study.
  • Travel to the study centre at NICM, Western Sydney University, Campbelltown or Westmead (NSW).

What are the benefits of participating?

  • You will be reimbursed up to $30 per visit for your travel expenses to the study centre.
  • You may experience improved cognition.
  • You will be helping to advance medical research, which could assist in the development of effective treatments in the future for people with Subjective Cognitive Complaints.

For more information, please contact:

Adele Cave
NICM Principal Investigator
p. 0487 472 273

Interested in participating?

Please complete and submit the following information.

Human Research Ethics Committee Approval: This clinical trial has been approved by Western Sydney University Human Research Ethics Committee (Approval Number: H11958). The study is supported by NICM, Western Sydney University and BioCeuticals. ACTRN12617000945325